瑞美松龙结构式
|
常用名 | 瑞美松龙 | 英文名 | Rimexolone |
|---|---|---|---|---|
| CAS号 | 49697-38-3 | 分子量 | 370.525 | |
| 密度 | 1.1±0.1 g/cm3 | 沸点 | 507.0±50.0 °C at 760 mmHg | |
| 分子式 | C24H34O3 | 熔点 | 258-268ºC | |
| MSDS | N/A | 闪点 | 274.5±26.6 °C |
瑞美松龙用途利美索酮(Org 6216)是一种具有抗炎活性的糖皮质激素类固醇。利美索酮可用作1%眼用混悬液,用于治疗眼部炎症[1][2]。 |
| 中文名 | 瑞美松龙 |
|---|---|
| 英文名 | Rimexolone |
| 英文别名 | 更多 |
| 描述 | 利美索酮(Org 6216)是一种具有抗炎活性的糖皮质激素类固醇。利美索酮可用作1%眼用混悬液,用于治疗眼部炎症[1][2]。 |
|---|---|
| 相关类别 | |
| 体外研究 | 利美索酮(Org 6216)在注射部位显示出高度增强的持久性,最小的系统效应,几乎不会诱发皮肤营养不良[1]。 |
| 体内研究 | 利美索酮(Org 6216)(0-450μg/只小鼠;关节内注射;一次)在单关节抗原诱导的关节炎小鼠中显示出延长的抗炎作用[1]。动物模型:雄性,8-12周龄C57Black/6小鼠,具有抗原诱导的关节炎[1]剂量:5、25、50、150、250、450μg/小鼠给药:关节内注射,一次结果:以剂量依赖性方式抑制关节炎。在450和150μ。导致软骨细胞蛋白多糖合成的抑制减少。 |
| 参考文献 |
| 密度 | 1.1±0.1 g/cm3 |
|---|---|
| 沸点 | 507.0±50.0 °C at 760 mmHg |
| 熔点 | 258-268ºC |
| 分子式 | C24H34O3 |
| 分子量 | 370.525 |
| 闪点 | 274.5±26.6 °C |
| 精确质量 | 370.250793 |
| PSA | 54.37000 |
| LogP | 4.01 |
| InChIKey | QTTRZHGPGKRAFB-OOKHYKNYSA-N |
| SMILES | CCC(=O)C1(C)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C |
| 蒸汽压 | 0.0±3.0 mmHg at 25°C |
| 折射率 | 1.559 |
| 储存条件 | 室温 |
|
~97%
瑞美松龙 49697-38-3 |
| 文献:Conrow, Raymond E. Journal of Organic Chemistry, 1999 , vol. 64, # 3 p. 1042 - 1044 |
|
~%
瑞美松龙 49697-38-3 |
| 文献:Conrow, Raymond E. Journal of Organic Chemistry, 1999 , vol. 64, # 3 p. 1042 - 1044 |
|
~%
瑞美松龙 49697-38-3 |
| 文献:Conrow, Raymond E. Journal of Organic Chemistry, 1999 , vol. 64, # 3 p. 1042 - 1044 |
|
~%
瑞美松龙 49697-38-3 |
| 文献:Conrow, Raymond E. Journal of Organic Chemistry, 1999 , vol. 64, # 3 p. 1042 - 1044 |
|
~%
瑞美松龙 49697-38-3 |
| 文献:Conrow, Raymond E. Journal of Organic Chemistry, 1999 , vol. 64, # 3 p. 1042 - 1044 |
|
~%
瑞美松龙 49697-38-3 |
| 文献:Conrow, Raymond E. Journal of Organic Chemistry, 1999 , vol. 64, # 3 p. 1042 - 1044 |
|
~%
瑞美松龙 49697-38-3 |
| 文献:Conrow, Raymond E. Journal of Organic Chemistry, 1999 , vol. 64, # 3 p. 1042 - 1044 |
|
~%
瑞美松龙 49697-38-3 |
| 文献:Conrow, Raymond E. Journal of Organic Chemistry, 1999 , vol. 64, # 3 p. 1042 - 1044 |
|
~%
瑞美松龙 49697-38-3 |
| 文献:Conrow, Raymond E. Journal of Organic Chemistry, 1999 , vol. 64, # 3 p. 1042 - 1044 |
| Rimexolone |
| (11β,16α,17β)-11-Hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one |
| 11β-Hydroxy-16α,17α-dimethyl-17-propionylandrosta-1,4-dien-3-one |
| 11b-Hydroxy-16a,17a-dimethyl-17-propionylandrosta-1,4-dien-3-one |
| (8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propionyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
| (8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propanoyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-on |
| (8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
| (11b,16a,17b)-11-Hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one |
| Asoprisnil ecamate |
| Androsta-1,4-dien-3-one, 11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)-, (11β,16α,17β)- |
| (8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-10,13,16,17-tétraméthyl-17-propanoyl-6,7,8,9,10,11,12,13,14,15,16,17-dodécahydro-3H-cyclopenta[a]phénanthrén-3-one |
| 11β-Hydroxy-16α,17,21-trimethyl-1,4-pregnadien-3,20-dion |
| (8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name) |
| (8S,9S,10R,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propionyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name) |
| VEXOL |